Abstract
Clinical genomic sequencing methods that produce a wide range of results are increasingly used in research and clinical settings. Some of these results are incidental or secondary findings, unrelated to the testing indication. The potential clinical significance of secondary findings varies, with some having limited to no medical actionability (hereafter referred to as LMA-SFs). Questions remain about whether and how to return LMA-SFs. Previous research found that patients had diverse responses to receiving secondary findings, including excitement, shock, and disbelief.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
